仟源医药：关于回购注销2025年限制性股票激励计划部分限制性股票的公告

Group 1 - The company announced the approval of a proposal to repurchase and cancel part of the restricted stock from the 2025 incentive plan due to two recipients no longer qualifying as incentive targets after leaving the company [2] - A total of 50,000 shares of restricted stock that were granted but not yet released from the lock-up period will be repurchased and canceled by the company [2] - The decision was made during the 36th meeting of the fifth board of directors held on January 13, 2026 [2]